1. Home
  2. PTGX vs MSGE Comparison

PTGX vs MSGE Comparison

Compare PTGX & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • MSGE
  • Stock Information
  • Founded
  • PTGX 2006
  • MSGE 2020
  • Country
  • PTGX United States
  • MSGE United States
  • Employees
  • PTGX N/A
  • MSGE N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • MSGE Services-Misc. Amusement & Recreation
  • Sector
  • PTGX Health Care
  • MSGE Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • MSGE Nasdaq
  • Market Cap
  • PTGX 2.8B
  • MSGE 1.9B
  • IPO Year
  • PTGX 2016
  • MSGE N/A
  • Fundamental
  • Price
  • PTGX $47.91
  • MSGE $42.38
  • Analyst Decision
  • PTGX Strong Buy
  • MSGE Buy
  • Analyst Count
  • PTGX 7
  • MSGE 5
  • Target Price
  • PTGX $52.83
  • MSGE $44.20
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • MSGE 250.5K
  • Earning Date
  • PTGX 11-08-2024
  • MSGE 11-05-2024
  • Dividend Yield
  • PTGX N/A
  • MSGE N/A
  • EPS Growth
  • PTGX N/A
  • MSGE 102.04
  • EPS
  • PTGX 2.75
  • MSGE 2.97
  • Revenue
  • PTGX $319,120,000.00
  • MSGE $959,265,000.00
  • Revenue This Year
  • PTGX $400.33
  • MSGE $4.45
  • Revenue Next Year
  • PTGX N/A
  • MSGE $5.29
  • P/E Ratio
  • PTGX $17.54
  • MSGE $14.34
  • Revenue Growth
  • PTGX 125.73
  • MSGE 12.66
  • 52 Week Low
  • PTGX $13.76
  • MSGE $27.55
  • 52 Week High
  • PTGX $48.89
  • MSGE $44.05
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • MSGE 56.30
  • Support Level
  • PTGX $45.33
  • MSGE $42.16
  • Resistance Level
  • PTGX $48.89
  • MSGE $42.98
  • Average True Range (ATR)
  • PTGX 1.28
  • MSGE 0.86
  • MACD
  • PTGX 0.11
  • MSGE -0.09
  • Stochastic Oscillator
  • PTGX 77.11
  • MSGE 55.50

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: